A PK-loading study of q3w Herceptin (trastuzumab) monotherapy in women with HER2 positive metastatic breast cancer
Phase of Trial: Phase IV
Latest Information Update: 23 Feb 2010
At a glance
- Drugs Trastuzumab (Primary)
- Indications Advanced breast cancer
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Roche
- 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 30 Mar 2007 New trial record.